CAR T Manufacturing in Japan Gets Boost from Teijin-Shinshu University Research Collaboration

Shinshu University Hospital's expertise in CAR T-cell therapy R&D and clinical application will be combined with Teijin Regenet's manufacturing and quality-management expertise cultivated through its CDMO business for regenerative medicine products.

The post CAR T Manufacturing in Japan Gets Boost from Teijin-Shinshu University Research Collaboration appeared first on GEN - Genetic Engineering and Biotechnology News.